<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03142503</url>
  </required_header>
  <id_info>
    <org_study_id>2012/18701-2</org_study_id>
    <nct_id>NCT03142503</nct_id>
  </id_info>
  <brief_title>The DIET Trial - Dietetic Intervention in Psoriatic Arthritis</brief_title>
  <acronym>DIET</acronym>
  <official_title>Effectiveness of a Dietary Intervention Program on Disease Activity, Metabolism and Oxidative Stress in Patients With Psoriatic Arthritis and Psoriasis Activity: A Clinical, Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <brief_summary>
    <textblock>
      Psoriasis (Ps) and psoriatic arthritis (PsA) are associated with increased risk of metabolic
      syndrome (MetS), body fatness and cardiovascular risk. Additionally, oxidative stress and
      inflammation are also contributing mechanisms on Ps and PsA. However, little is known about
      the influence of diet and micronutrients on the main outcomes of these diseases. The aim of
      the investigators is to evaluate the effectiveness of an intervention diet program on disease
      activity, metabolic profile and oxidative stress inpatients with Psoriasis and Psoriatic
      Arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 21, 2013</start_date>
  <completion_date type="Actual">June 22, 2015</completion_date>
  <primary_completion_date type="Actual">March 16, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>To evaluate the increase of Minimal Disease Activity (MDA) after intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fat Mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>To analyze the decrease of Fat Mass Index (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lean Mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>To evaluate the increase of Muscle Mass (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>12 weeks</time_frame>
    <description>To observe the improvement of waist circumference (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>12 weeks</time_frame>
    <description>To analyze the improvement of Body Mass Index (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycation markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>To analyze the decrease of receptor for advanced glycation end products receptor (RAGE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti-inflammatory marker</measure>
    <time_frame>12 weeks</time_frame>
    <description>To analyze the increase of adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipidic Peroxidation</measure>
    <time_frame>12 weeks</time_frame>
    <description>To analyze the improvement of malondialdehyde (TBARs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>To observe the improvement of LDL fractions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cutaneous activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>To evaluated the reduction in cutaneous activity, evaluated by PASI (Psoriasis Area Severity Index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Articular activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>To evaluate the decrease of articular activity, evaluated by DAS28-CRP (Disease Activity Score-C reactive protein) and DAS28-ESR (Disease Activity Score-Erythrocyte Sedimentation Rate).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Arthritis, Psoriatic</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Soybean supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet + placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Soybean supplementation and diet intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet + Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Omega 3 and diet intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Diet + supplementation</intervention_name>
    <description>Supplementation of 1g of fish oil, 3 time a day, and hypocaloric diet (-500 calories) for 12 weeks, to evaluate weight loss, antioxidant markers and disease activity.</description>
    <arm_group_label>Diet + Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Diet + placebo</intervention_name>
    <description>Supplementation of 1g of soybean oil, 3 times a day, and hypocaloric diet (-500 calories) for 12 weeks, to evaluate weight loss, antioxidant markers and disease activity.</description>
    <arm_group_label>Diet + placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Supplementation of 1g soybean oil, 3 times a day.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with psoriatic arthritis, according to the Classification Criteria of
             Psoriatic Arthritis (CASPAR)

        Exclusion Criteria:

          -  lack of written informed consent;

          -  age &lt; 18 years old;

          -  history of gastrointestinal, endocrine, pulmonary, kidney, hepatic, and neuromuscular
             diseases, as well as HIV-positive;

          -  pregnant or breast-feeding women;

          -  previous history of cancer;

          -  use of steroids, protein supplements, vitamins, multivitamins, or antioxidants.

          -  Specific medications to PsA and physical activity were required to be stable for the
             last 3 months to be included in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Marcelo M Pinheiro</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>psoriatic arthritis</keyword>
  <keyword>psoriasis</keyword>
  <keyword>body composition</keyword>
  <keyword>DXA measurements</keyword>
  <keyword>spondyloarthritis</keyword>
  <keyword>diet therapy</keyword>
  <keyword>adipose tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

